Hemispherx Biopharma’s Collaborative Partner in Japan, Biken Corp., Expands Production Capacity for Swine/Avian Flu Vaccines

June 12, 2009 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

PHILADELPHIA, June 12, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE AMEX:HEB) announced today that its collaborative influenza vaccine development partner in Japan, Biken, has decided to expand its Flu production capacity significantly.

Twitter
LinkedIn
Facebook
Email
Print

Alliances